Miniatura

Fitxers

678886.pdf (644.58 KB)

Tipus de document

Article

Versió

Versió publicada

Data de publicació

2017-11-29

Llicència de publicació

cc-by-nc (c) Esquinas López, Cristina et al., 2017
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/124084

Gene and miRNA expression profiles in PBMCs from patients with severe and mild emphysema and PiZZ alpha1-antitrypsin deficiency

Títol de la revista

Autors

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

https://doi.org/10.2147/COPD.S145445

Resum

Introduction: COPD has complex etiologies involving both genetic and environmental determinants. Among genetic determinants, the most recognized is a severe PiZZ (Glu342Lys) inherited alpha1-antitrypsin deficiency (AATD). Nonetheless, AATD patients present a heterogeneous clinical evolution, which has not been completely explained by sociodemographic or clinical factors. Here we performed the gene expression profiling of blood cells collected from mild and severe COPD patients with PiZZ AATD. Our aim was to identify differences in messenger RNA (mRNA) and microRNA (miRNA) expressions that may be associated with disease severity. Materials and methods: peripheral blood mononuclear cells from 12 COPD patients with PiZZ AATD (6 with severe disease and 6 with mild disease) were used in this pilot, high-throughput microarray study. We compared the cellular expression levels of RNA and miRNA of the 2 groups, and performed functional and enrichment analyses using the Kyoto Encyclopedia of Genes and Genomes (KEGG) and Gene-ontology (GO) terms. We also integrated the miRNA and the differentially expressed putative target mRNA. For data analyses, we used the R statistical language R Studio (version 3.2.5). Results: the severe and mild COPD-AATD groups were similar in terms of age, gender, exacerbations, comorbidities, and use of augmentation therapy. In severe COPD-AATD patients, we found 205 differentially expressed genes (DEGs) (114 upregulated and 91 downregulated) and 28 miRNA (20 upregulated and 8 downregulated) compared to patients with mild COPD-AATD disease. Of these, hsa-miR-335-5p was downregulated and 12 target genes were involved in cytokine signaling, MAPK/mk2, JNK signaling cascades, and angiogenesis were much more highly expressed in severe compared with mild patients. Conclusions: despite the small sample size, we identified downregulated miRNA (hsa-miR-335) and the activation of pathways related to inflammation and angiogenesis on comparing patients with severe vs mild COPD-AATD. Nonetheless, our findings warrant further validation in large studies.

Matèries

Malalties pulmonars obstructives cròniques, Errors congènits del metabolisme, Micro RNAs, Expressió gènica

Matèries (anglès)

Chronic obstructive pulmonary diseases, Inborn errors of metabolism, MicroRNAs, Gene expression

Citació

Col·leccions

Articles publicats en revistes (Infermeria de Salut Pública, Salut mental i Maternoinfantil)

Citació

ESQUINAS LÓPEZ, Cristina, JANCIAUSKIENE, Sabina, GONZALO, Ricardo, MAS DE XAXARS GINER, Gemma, OLEJNICKA, Beata, BELMONTE, Irene, BARRECHEGUREN, Miriam, RODRÍGUEZ, Esther, NUÑEZ, Alexa, RODRÍGUEZ-FRÍAS, Francisco, MIRAVITLLES FERNÁNDEZ, Marc. Gene and miRNA expression profiles in PBMCs from patients with severe and mild emphysema and PiZZ alpha1-antitrypsin deficiency. _International Journal of Chronic Obstructive Pulmonary Disease_. 2017. Vol. 12, núm. 3381-3390. [consulta: 24 de gener de 2026]. ISSN: 1176-9106. [Disponible a: https://hdl.handle.net/2445/124084]

Exportar metadades

JSON - METS

Compartir registre